Jet Injector Drug Delivery: Promise and Pitfalls

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Jet Injector Drug Delivery: Promise and Pitfalls

Topic: Bio Break
YouTube video thumbnail

In this episode of Bio Break, Nick and Nigel dive into the world of jet injector drug delivery. This needle-free method, made popular in science fiction and real-world vaccines, is still used today. But while the idea of a high-pressure, pain-free injection sounds ideal, the conversation uncovers key limitations.

What Is a Jet Injector?

Jet injectors deliver drugs by forcing liquid medication through the skin using high pressure, eliminating the need for a needle. That pressure forms a thin stream that penetrates the skin, ideally resulting in less pain than traditional injections. The technology has been around since the 1960s and remains popular in certain applications.

Less Pain, More Problems?

While jet injector drug delivery may reduce pain, Nigel highlights concerns. The high pressure can cause side spray, potentially wasting expensive medications. There’s also the risk of cross-contamination, especially when parts of the injector are reused. Additionally, some advanced drugs—like those using lipid nanoparticles for mRNA vaccines—may be incompatible due to shear forces that can damage sensitive payloads.

Why Jet Injectors Are Still Around

Despite the challenges, jet injectors offer clear benefits in usability. They provide a quick, needle-free option that appeals to patients and practitioners alike. However, understanding their limitations is key to deciding when they’re the right tool for the job.

Rightness Trap Medtech concept showing a crossroads decision with opposing directional signs

Jason McGee explores how the Rightness Trap Medtech dynamic can quietly erode enterprise value in medical device companies.

Gram positive vs negative bacteria explained with diagram and comparison

Understanding gram positive vs negative bacteria is essential when studying sterility, microbiology, and antibiotic effectiveness. While many people think the difference is only about staining, the reality is much deeper.

Alcohol disrupting bacterial cell membrane explaining why 70 percent sanitizer kills bacteria more effectively

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips of StarFish Medical and Peter van der Velden of Lumira Ventures speaking at a MedTech transactions webinar

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.